Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludarabine and Cyclophosphamide in Previously Untreated B-cell CLL
NCT00003829Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Aug 1999
- Primary completion
- May 2001
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine, cyclophosphamide in chronic lymphocytic leukemia (CLL), sponsored by Cancer and Leukemia Group B. Started Aug 1999; status: completed.
02
Drugs
fludarabinecyclophosphamide
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00003829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003829.